Coala Life was founded in Sweden with a mission to develop patient-centric solutions powered by smart algorithms. The solutions aim to digitally transform the field of cardiac diagnostics, to help win the battle against the world’s leading cause of death - heart disease.

Coala heart Monitor

The COALA Heart Monitor is used by thousands of patients and over 300 connected providers to help remotely detect and diagnose heart disease, as well as alleviate worries. Our unique innovations have received multiple prestigious awards and supported by over USD 20 million in funding.

We make it possible for everyone to monitor and analyze their heart. Anytime, anywhere.

18.08.17.Coala_2_127-e1552896885285.png

Passion for the heart

Coala Life is run by an entrepreneurial team with broad knowledge, passion and experience in the heart. Many with long careers at St. Jude Medical (now Abbott). In collaboration with leading clinicians and industry experts, we've developed and launched a multi-prize-winning portfolio of cardiac monitoring solutions.

It's all centered around the Coala Heart Monitor, a cloud-based product and service for real-time analysis of the heart. The Coala is unique in detecting Atrial Fibrillation based on both P-wave detection and RR variability, as well as the ability to help detect murmurs.

Digital revolution

Real-time cardiac diagnostics

COALA is a unique medical innovation based on more than 10 years of R&D, with more than 20 patents and over 15 industry awards.

A device and cloud-based solution including a high-performance stethoscope, three integrated electrodes to capture diagnostic-quality ECG and smart algorithms enabling real-time analysis of data.

Contact us for a demo

Virtual cardiac diagnostics

The COALA is ideal to prescribe to patients with palpitations and intermittent symptoms of possible arrhythmias that need a long-term monitoring solution.

Its unique dual-lead ECG solution captures accurate, clinically relevant cardiac data when symptoms occur. It’s the only smartphone-based solution with automatic AF detection based on advanced pattern recognition algorithms.

The real-time visibility to results ensures physicians can efficiently progress symptomatic patients along the treatment path.

- 300+connected clinics
- 30billiondatapoints analyzed
- 87%PPV accuracy

Smart algorithms

The only smartphone system with P-wave based AF detection

The COALA is a CE and FDA 510(k) cleared device supported by strong clinical data with thousands of users. The chest-ECG with synchronized heart sound recording and thumb-ECG is transmitted via Bluetooth to maximize quality, precision and accuracy - with less artifacts and minimized false positives.

COALA’s smart algorithms analyze the recordings based on pattern recognition, P-waves and RR variability. Conventional 1-lead ECGs typically only detect AF based on RR variability, which result in high false positives. The COALA has been proven to be 300% more accurate than standard 1-lead ECG solutions, typically used in watches and other portable ECG’s.

Coala Care Portal

Real-time reports

State-of-the-art 1,000 Hz and 24-bit ECG digital architecture and data analyzed by high-performance cloud-based platform.

The HIPAA-compliant Coala Care portal presents data in real-time to providers and includes a smart report generator with ability to manually annotate and download raw data for further analysis.

Published data has not only proved high sensitivity and specificity for the system, but also a PPV of 87% for automatic AF detection.

Reduce symptoms, anxiety and depression

Clinically proven to improve quality of life

The COALA was used in the groundbreaking RedHeart Study by the Karolinska Institute (Stockholm, Sweden) and included nearly 1,000 women and over 280,000 ECG recordings in everyday life. The study showed an increase in quality of life in women with palpitations, because of the instant results that helped reduce symptoms, anxiety and depression.

The COALA is currently used in multiple clinical studies including the TEASE-study on cryptogenic stroke patients. The COALA is provided to patients to help detect AF post-admission for an extended period of time at home. Results to be presented in 2020.

The COALA is ideal for user-centered studies and for collecting large amounts of ECG data and heart sounds in geographically distributed groups. COALA's market-leading performance is clinically evaluated and is based on research findings presented at several national and international research conferences.

The Coala Care portal provides web-based access to real-time patient data with abilities to interpret, annotate and download raw data for further analysis. It’s all Microsoft Azure based with secure storage in the US and Europe.

THE BOARD

Liselott Kilaas (chair), Johanna Öberg, Ebba Fåhraeus, Sören Olofsson, Anders Rodebjer and Jan Flood.

Liselott has an impressive career as, among others, CEO of Aleris, the largest private healthcare provider in the Nordics. Liselott has been on the Board of Telenor ASA and the Central Bank of Norway, to mention a few assignments. Sören has been the CEO of some of Swedens largest hospitals, he laid the foundation of e-health in Sweden and he advises the European Union on digitization of health. Johanna is the CEO of Memira, the largest healthcare provder in the Nordics within eye lens replacement surgery. Ebba is a super star of entrepreneurship and innovation, and among others, the CEO of SmiLe Incubator. Anders R has medical degree and is the super corporate finance guy. Jan is a great lawyer and one of the founding investors of the company.

CLINICAL ADVISORY BOARD

Jerome V. Dwyer, MD, MBA, Cardiologist and Electrophysiologist, St. Louis Cardiology Center. Dr. Dwyer is a serial entrepreneur, investor, fundraiser, advisor, and physician whose passion is creating and growing new businesses and helping others to do the same.

Joseph P. Galichia, MD, FACC, is a world renowned cardiologist and one of the pioneers of angioplasty in the United States. Dr. Galichia was twice elected president of the International Society of Cardiovascular Interventionists and founded the Galicia Heart Hospital - the first hospital exclusively devoted to interventional cardiology.

Gil Vardi, MD, Cardiologist, partner of SLHV and Clinical Assistant Professor of Medicine at Washington University School of Medicine in St. Louis. Dr. Gil Vardi was selected as one of “America’s Best Physicians” for 2019 by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Muhammad Mustafa, MD, FACC. Bond Clinic Cardiologist, Winter Haven Hospital. Clinical Excellence Council Chairman, Medical Director of Echocardiography and Medical Director of Nuclear Cardiology.

Karen J. McConnell, PharmD, FCCP, FASHP, BCPS. System Director, Clinical Pharmacy Services at Catholic Health Initiatives (CHI). Karen has previous experience from among others Cardinal Health, Kaiser Permanente and has published more than 35 scientific publications.

Reginald G. Abraham, M.D., FACS, FACC, FCCP. Chief of CardioThoracic Surgery and Chief of Staff Elect at Fountain Valley Regional Hospital, California.

David L. Gould, M.D., FACS, Urology and Transplant Surgeon and director of Urologic and Reconstructive Genitourinary Surgery. Affiliated with Baylor Scott & White All Saints Medical Center, Medical City Fort Worth and Texas Health Harris Methodist

Tord Juhlin, MD, PhD, Senior consultant and Cardiologist, Skåne University Hospital, Sweden. Tord is also the Chairman of the Swedish Cardiology Societies Heart Rhythm Group (HRG).

Hans-Jörgen Nilsson, MD, PhD, Workstream Lead Cardiology, Senior consultant and Cardiologist, Skåne University Hospital, Sweden. Hans-Jörgen is currently active in the cardiology implementation of new region wide EMR system in Region Skåne.

Claes Held, MD, PhD, Senior consultant and Professor in Cardiology, Akademiska Hospital Uppsala (The Uppsala University Hospital), Sweden. Claes is also a researcher active at Uppsala Clinical Research Center (UCR)

Ulf Tossman, PhD Neuropharmacology, CEO Orphelion AB, Co-founder of Coala Life AB. Ulf is also chairman/board member of several Swedish Life-science companies.

1 Member

Join Us!

You need to be a member of Heart Health Community to add comments!

Join Heart Health Community

Comments are closed.

Forum

Coala Life is ready to support remote management of high-risk cardiovascular patients

Coala Life is ready to support remote management of high-risk cardiovascular patients #NEWS 03/16/2020 In response to COVID-19 and its impact on patient care, Coala Life stands ready to scale-up operations in an effort to enable a continuum of care; addressing individuals with cardiovascular disease who are among the highest risk groups of adverse outcomes from COVID-19. Enabling home-based cardiac monitoring The Coala Heart Monitor service enables real-time remote cardiac monitoring,…

Started by Stephen Page

0 Replies

FDA cleared Coala Heart Monitor now enables virtual heart and lung exams from a patient’s home

FDA cleared Coala Heart Monitor now enables virtual heart and lung exams from a patient’s home #PRESSRELEASE 04/15/2020 Swedish Heart-Lung Home Monitor Expands Indications for use in COVID-19 Respiratory Diagnostic Exams Irvine, CA, April 15th, 2020 – Coala Life, a leading Swedish digital health company has, as supported by FDA’s Emergency Guidance, expanded the indication for use enabling physicians to remotely, in real-time, monitor patients’ hearts and lung sounds. The Coala Heart…

Started by Stephen Page

0 Replies

Coala Life and My Cardiologist to roll-out the largest Real-Time Cardiac Monitoring program in Florida

Coala Life and My Cardiologist to roll-out the largest Real-Time Cardiac Monitoring program in Florida #PRESSRELEASE 07/22/2020 Remote Patient Monitoring (RPM) program enabling long-term and real-time cardiac monitoring of patients in the safety of their homes Irvine, CA, July 22, 2020 / PRN / – Coala Life, the award-winning Swedish innovator of real-time remote cardiac monitoring solutions and the Florida-based My Cardiologist group have partnered to roll-out the most comprehensive cardiac…

Started by Stephen Page

0 Replies

Scientific publication in the British Medical Journal proves the efficacy of Coala Heart Monitor as part of cryptogenic stroke management

Scientific publication in the British Medical Journal proves the efficacy of Coala Heart Monitor as part of cryptogenic stroke management #PRESSRELEASE 10/07/2020 Uppsala, Sweden, October 07, 2020 – Coala Life, today announced the results of a late-breaking trial on cryptogenic stroke (stroke of unknown cause) patients. In the TEASE-study, recently published in the British Medical Journal (BMJ Open, Aug 2020), the Coala Heart Monitor was used to evaluate 100 patients after cryptogenic…

Started by Stephen Page

0 Replies

Coala Life

Passion for the heart

The COALA
Real-time Heart Monitoring System

Prescribe. Diagnose. Act.

Virtual cardiac diagnostics

Enabling true real-time Telemedicine

"We prescribe the Coala in our general practice"

300% more accurate than single-lead ECG

Clinically proven to increase efficiency and patient satisfaction

Remote lung auscultation

1. INDUSTRY LEADING CAPABILITIES

2. PRESCRIBE UNTIL DIAGNOSIS

3. RISK FREE BUSINESS MODEL

Digital revolution

A ground-breaking Swedish innovation

Meeting clinical pain points